The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; BeiGene; Bristol-Myers Squibb; Merck; Takeda
Expert Testimony - Astellas Pharma; AstraZeneca; BeiGene; Bristol-Myers Squibb; Merck; Takeda
AGITG ASCEND: Randomised, double-blind phase II study of certepetide or placebo added to gemcitabine plus nab-paclitaxel in patients with untreated metastatic pancreatic ductal adenocarcinoma: Initial results.
 
Andrew Dean
Leadership - Valo Therapeutics
Stock and Other Ownership Interests - A2A Pharmaceuticals
Honoraria - Amgen; Juniper Pharmaceuticals
Speakers' Bureau - Juniper Biologics
Travel, Accommodations, Expenses - Juniper Biologics; Juniper Biologics; Novartis
(OPTIONAL) Uncompensated Relationships - A2A Pharmaceuticals
 
Katrin Sjoquist
Honoraria - Astellas Pharma; Bayer (Inst); BMS; Glenmark (Inst); Lisata (Inst); MSD; Novotech (Inst); SERVIER
Research Funding - Bayer (Inst)
Other Relationship - Novotech
 
Val Gebski
No Relationships to Disclose
 
Christos Karapetis
Honoraria - Eisai; MSD Oncology; Roche
Consulting or Advisory Role - AstraZeneca; Bayer; BeiGene; Boehringer Ingelheim; Bristol-Myers Squibb; Eisai; Gilead Sciences; Ipsen; Lilly; Merck Serono; Pierre Fabre; Roche; Takeda
 
Chris Lomma
Consulting or Advisory Role - AstraZeneca
 
Matthew Burge
Stock and Other Ownership Interests - coclear; CSL Limited; pfizer
Honoraria - AstraZeneca; Bristol Myers squibb; Merck Sharp & Dohme; SERVIER
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb/Medarex; merck srpe Dohme; SERVIER
Speakers' Bureau - Merck Sharpe Dohme
Research Funding - Amgen (Inst)
Patents, Royalties, Other Intellectual Property - funding for an investigator initiated prospective trial (Inst)
 
Christopher Steer
Honoraria - AstraZeneca; Eisai; Novartis
Consulting or Advisory Role - Ipsen; Janssen; MSD; Sanofi
 
Niall Tebbutt
No Relationships to Disclose
 
Belinda Lee
Honoraria - Roche
Research Funding - AngioDynamics (Inst); Servier (Inst); Specialised Therapeutics (Inst)
Travel, Accommodations, Expenses - Ipsen; Roche
 
Christopher Jackson
No Relationships to Disclose
 
Fiona Day
Speakers' Bureau - AstraZeneca
Research Funding - AstraZeneca/MedImmune; Bristol-Myers Squibb; Varian Medical Systems
Travel, Accommodations, Expenses - Merck
 
Shamsudheen Padinharakam
No Relationships to Disclose
 
James Murray
No Relationships to Disclose
 
Sonia Yip
Travel, Accommodations, Expenses - Bayer
 
Jan Mumford
No Relationships to Disclose
 
Derrick Siu
No Relationships to Disclose
 
Joanna Lee
No Relationships to Disclose
 
Yan Ru Gao
No Relationships to Disclose
 
Marion Harris
No Relationships to Disclose
 
Timothy Price
Consulting or Advisory Role - Amgen; Astrazeneca (Inst); BMS (Inst); Merck; Takeda
Research Funding - AMGEN (Inst)
Travel, Accommodations, Expenses - Amgen